See, R E <br/><br/>
Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats.  [electronic resource] 

 -  Neuroscience letters  Aug 1992 
 - 100-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0304-3940 
<br/><br/><label>Standard No.: </label>10.1016/0304-3940(92)90629-l  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3,4-Dihydroxyphenylacetic Acid--metabolism<br/>Animals<br/>Corpus Striatum--metabolism<br/>Dialysis--methods<br/>Dopamine--metabolism<br/>Dopamine Antagonists<br/>Female<br/>Haloperidol--administration & dosage<br/>Homovanillic Acid--metabolism<br/>Hydroxyindoleacetic Acid--metabolism<br/>Raclopride<br/>Rats<br/>Rats, Sprague-Dawley<br/>Salicylamides--pharmacology<br/>Time Factors